Embed presentation




























A dynamic force in pharmaceutical research and innovation, Barbara Maglione has redefined leadership in R&D through her unwavering commitment to scientific integrity, collaboration, and human-centered innovation. At Farmaceutici Damor, she has led transformative projects that bridge science and compassion but the most notable is the 𝐁𝐢𝐨𝐚𝐫𝐠𝐢𝐧𝐢𝐧𝐚® 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡, developed in collaboration with Professors Trimarco, Fiorentino, and Santulli, which demonstrated remarkable outcomes in COVID-19 sub-intensive care patients.



























